Saatja: "EURO TB" <
[email protected]>
Saaja: "Anniki Lai", "Triin Uusberg"
Teema: Invitation to Regional Meeting on 28-29 January 2025, Copenhagen, Denmark - Improving Access and Availability of Medicines for TB and DR-TB in Europe
Kuupäev: 2024-11-25 12:09
Tähelepanu! Tegemist on välisvõrgust saabunud kirjaga.
Tundmatu saatja korral palume linke ja faile mitte avada.
Tähelepanu! Tegemist on välisvõrgust saabunud kirjaga.
Tundmatu saatja korral palume linke ja faile mitte avada. Dear Ms
Lai,
Please find attached correspondence from the WHO Regional Office for
Europe with an invitation to the Second Regional Meeting on Improving
Access and Availability of Medicines for TB and DR-TB in Europe, which
will take place on 28-29 January 2025 in Copenhagen, Denmark.
Yours sincerely,
TB and AMP teams
WHO Regional Office for Europe
Askar Yedilbayev, MD, MPH
Regional Adviser, TB and DR-TB
Joint Infectious Diseases Unit (JID)
Division of Communicable Diseases, Environment and Health (CDE)
Tel. +45 45 33 7057; Mobile: +45 911 75 030
Email:
[email protected]; Website: www.euro.who.int
WORLD HEALTH ORGANIZATION Date: 25 November 2024
ORGANISATION MONDIALE DE LA SANTÉ
WELTGESUNDHEITSORGANISATION
ВСЕМИРНАЯ ОРГАНИЗАЦИЯ ЗДРАВООХРАНЕНИЯ Ms Anniki Lai
Deputy Secretary General on Health
REGIONAL OFFICE FOR EUROPE Ministry of Social Affairs
BUREAU RÉGIONAL DE L’EUROPE
REGIONALBÜRO FÜR EUROPA Suur-Ameerika 1
ЕВРОПЕЙСКОЕ РЕГИОНАЛЬНОЕ БЮРО 10122 Tallinn
Head office:
Estonia
UN City, Marmorvej 51,
DK-2100 Copenhagen Ø, Denmark
Tel.: +45 45 33 70 00; Fax: +45 45 33 70 01
Email:
[email protected]
Website: https://www.who.int/europe
Dear Ms Lai,
Invitation to Second Regional Meeting on Improving Access and Availability of Medicines for TB and
DR-TB in Europe, 28-29 January 2025, Copenhagen, Denmark
Over recent years, many EU Member States have reported increasing challenges in securing essential
medicines for TB and DR-TB treatment regimens. In response, the WHO Regional Office for Europe (WHO
EURO) has launched a comprehensive survey to assess and address the challenges of accessing TB and DR-TB
medicines across Western Europe. This survey, distributed on 8 November, was sent to 30 Member States,
including the EU, the United Kingdom, Norway, and Switzerland, targeting the designated national TB focal
point and colleagues previously involved in discussions on TB medicine access.
We kindly request your support in ensuring that relevant national entities are aware of and contribute to
completing the survey. Responses will require coordination across your country to provide a collective input.
The survey results will inform strategies to strengthen procurement mechanisms and foster a coordinated
regional approach. Findings will be presented at the Second Regional Meeting on Improving Access and
Availability of Medicines for TB and DR-TB in Europe, to be held on 28-29 January 2025 at WHO
Regional Office for Europe, UN City, 51 Marmorvej, Copenhagen, Denmark.
We are pleased to invite you to this meeting and kindly ask you to nominate representatives from the national
drug regulatory authority, as well as officers responsible for coordinating procurement and supply management
of TB medicines, to join the meeting. WHO strongly encourages in-person attendance; however, remote
participation will also be available to expand accessibility.
Please note that while WHO will provide lunches and refreshments, travel and accommodation expenses cannot
be covered.
For planning purposes, we ask that you submit nominations by 17 December 2024 to
[email protected] and Dr.
Askar Yedilbayev, Regional TB Adviser, at
[email protected].
We hope you will find this opportunity valuable and look forward to welcoming you to Copenhagen
Yours sincerely,
Mr Robb Butler
Director,
Division of Communicable Diseases, Environment and Health
UN City, Marmorvej 51 Tel.: +45 45 33 70 00 Email:
[email protected]
DK-2100 Copenhagen Ø Fax: +45 45 33 70 01 Website: https://www.who.int/europe
Denmark
Copy for information to:
Ms Helen Sõber, Adviser, European Union Affairs and International Co-operation Department, Ministry of Social Affairs,
Suur-Ameerika 1, 10122 Tallinn, Estonia
Ms Triin Uusberg Head European Union Affairs and International Co-operation Department Ministry of Social Affairs
Suur-Ameerika 1 Tallinn 10129 Estonia .
Ms Riia Salsa-Audiffren Ambassador Representative of the Republic of Estonia Permanent Mission of the Republic of
Estonia to the United Nations Office and other international organizations in Geneva Chemin du Petit-Saconnex 28A
Genève CH-1209 Switzerland
H.E. Mr Andre Pung Ambassador Extraordinary and Plenipotentiary Embassy of the Republic of Estonia Frederiksgade
19, 4th floor Copenhagen K 1265Denmark
Ms Kristina Köhler, Liaison Officer, WHO Country Office, Estonia, Paldiski Road 81, 10617 Tallinn, Estonia
–2–